138 related articles for article (PubMed ID: 24104601)
1. Variations in serum TARC and I-TAC levels reflect minor changes in disease activity and pruritus in atopic dermatitis.
Kimura T; Sugaya M; Suga H; Morimura S; Miyamoto A; Kai H; Kagami S; Yanaba K; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Acta Derm Venereol; 2014 May; 94(3):331-2. PubMed ID: 24104601
[No Abstract] [Full Text] [Related]
2. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis.
Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K
Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603
[TBL] [Abstract][Full Text] [Related]
3. [Biomarker of atopic dermatits -focusing on serum TARC/CCL17 level as severity marker-].
Saeki H
Arerugi; 2013 Feb; 62(2):131-7. PubMed ID: 23531648
[No Abstract] [Full Text] [Related]
4. Serum thymus and activation-regulated chemokine (TARC) and interleukin-31 levels as biomarkers for monitoring in adult atopic dermatitis.
Kyoya M; Kawakami T; Soma Y
J Dermatol Sci; 2014 Sep; 75(3):204-7. PubMed ID: 24984931
[No Abstract] [Full Text] [Related]
5. Correlation between serum thymus and activation-regulated chemokine levels and stratum corneum barrier function in healthy individuals and patients with mild atopic dermatitis.
Furue M; Matsumoto T; Yamamoto T; Takeuchi S; Esaki H; Chiba T; Yamaguchi H
J Dermatol Sci; 2012 Apr; 66(1):60-3. PubMed ID: 22391243
[TBL] [Abstract][Full Text] [Related]
6. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC
Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
[TBL] [Abstract][Full Text] [Related]
7. [TARC (thymus and activation regulated chemokine)].
Nakamura K
Nihon Rinsho; 2010 Jun; 68 Suppl 6():41-5. PubMed ID: 20941997
[No Abstract] [Full Text] [Related]
8. Thymus and activation regulated chemokines in children with atopic dermatitis: Kyushu University Ishigaki Atopic Dermatitis Study (KIDS).
Furusyo N; Takeoka H; Toyoda K; Murata M; Maeda S; Ohnishi H; Fukiwake N; Uchi H; Furue M; Hayashi J
Eur J Dermatol; 2007; 17(5):397-404. PubMed ID: 17673383
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of thymus and activation-regulated chemokine can be used in the clinical evaluation of atopic dermatitis.
Gu CY; Gu L; Dou X
Int J Dermatol; 2015 Jul; 54(7):e261-5. PubMed ID: 26108268
[TBL] [Abstract][Full Text] [Related]
10. Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels.
Miyagaki T; Sugaya M; Suga H; Morimura S; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):19-24. PubMed ID: 22077186
[TBL] [Abstract][Full Text] [Related]
11. Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis.
Kou K; Aihara M; Matsunaga T; Chen H; Taguri M; Morita S; Fujita H; Yamaguchi Y; Kambara T; Ikezawa Z
Arch Dermatol Res; 2012 May; 304(4):305-12. PubMed ID: 22146836
[TBL] [Abstract][Full Text] [Related]
12. Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severity.
Landheer J; de Bruin-Weller M; Boonacker C; Hijnen D; Bruijnzeel-Koomen C; Röckmann H
J Am Acad Dermatol; 2014 Dec; 71(6):1160-6. PubMed ID: 25199679
[TBL] [Abstract][Full Text] [Related]
13. Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis.
Kataoka Y
J Dermatol; 2014 Mar; 41(3):221-9. PubMed ID: 24628072
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis.
Nakazato J; Kishida M; Kuroiwa R; Fujiwara J; Shimoda M; Shinomiya N
Pediatr Allergy Immunol; 2008 Nov; 19(7):605-13. PubMed ID: 18266834
[TBL] [Abstract][Full Text] [Related]
15. Nocturnal wrist movements are correlated with objective clinical scores and plasma chemokine levels in children with atopic dermatitis.
Hon KL; Lam MC; Leung TF; Kam WY; Lee KC; Li MC; Fok TF; Ng PC
Br J Dermatol; 2006 Apr; 154(4):629-35. PubMed ID: 16536804
[TBL] [Abstract][Full Text] [Related]
16. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.
Jahnz-Rozyk K; Targowski T; Paluchowska E; Owczarek W; Kucharczyk A
Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816
[TBL] [Abstract][Full Text] [Related]
17. Serum TARC and CTACK concentrations in children with atopic dermatitis, allergic asthma, and urticaria.
Machura E; Rusek-Zychma M; Jachimowicz M; Wrzask M; Mazur B; Kasperska-Zajac A
Pediatr Allergy Immunol; 2012 May; 23(3):278-84. PubMed ID: 22017510
[TBL] [Abstract][Full Text] [Related]
18. Elevated umbilical cord serum TARC/CCL17 levels predict the development of atopic dermatitis in infancy.
Miyahara H; Okazaki N; Nagakura T; Korematsu S; Izumi T
Clin Exp Allergy; 2011 Feb; 41(2):186-91. PubMed ID: 21054588
[TBL] [Abstract][Full Text] [Related]
19. An ultra-sensitive clinical biomarker assay: quantitation of thymus and activation-regulated chemokine in human plasma.
Zhao X; Delgado L; Weiner R; Laterza OF
Bioanalysis; 2014 Apr; 6(8):1069-80. PubMed ID: 24830891
[TBL] [Abstract][Full Text] [Related]
20. Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis.
Kwakkel-van Erp JM; Haeck IM; Paantjens AW; van de Graaf EA; van Ginkel WG; Knol MJ; de Bruin-Weller MS; Lammers JW; Knol EF; Bruijnzeel-Koomen C; Otten HG
J Am Acad Dermatol; 2010 Sep; 63(3):e70-2. PubMed ID: 20708466
[No Abstract] [Full Text] [Related]
[Next] [New Search]
